Tirzepatide Dosage Calculator: mg, Bac Water & Exact Syringe Units

Reconstituting a tirzepatide vial comes down to one number: how many units do you draw on the syringe? This calculator gives you that in one step. Enter how many milligrams are in your vial, how much bacteriostatic water you're adding, and your target dose, and it returns the exact insulin-syringe mark, the concentration you've made, and how many weekly doses the vial holds.

Tirzepatide is dosed in milligrams but drawn in units, and the bridge between the two is the concentration you create when you mix the vial. Get that bridge wrong and a 2.5 mg dose can look like "25 units" or "50 units" depending entirely on how much water you used. Below the tool we walk through the math, show where each titration dose (2.5 through 15 mg) lands on the syringe, and, because we run a tracking app, show what thousands of real tirzepatide users actually mix. For the drug itself, the brands, results, and safety, start with our complete tirzepatide guide; if you're still comparing options, see the best peptides for weight loss.

Key Takeaways

• Two-step math: concentration = vial mg ÷ bac water mL, then units = (dose mg ÷ concentration) × 100 on a U-100 syringe.
• Anchor example: a 10 mg vial + 2 mL of bacteriostatic water = 5 mg/mL; a 2.5 mg starting dose = 0.5 mL = the 50-unit mark, and the vial gives 4 weekly doses.
• More water = a more diluted vial = a larger number of units for the same milligram dose. The amount of tirzepatide you get never changes with the water.
• Compounded vials need this calculator; brand pens (Mounjaro/Zepbound) do not — they're pre-set fixed doses.
• Titration changes your unit mark. As you move 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg, recheck the draw; on a 5 mg/mL vial, 5 mg is already a full 100-unit syringe.
• No self-dosing recommendation here. FDA-approved tirzepatide titrates 2.5 mg weekly, +2.5 mg every ≥4 weeks, to a 15 mg max — a clinical decision, not this tool's output.

How do you calculate a tirzepatide dose?

Tirzepatide reconstitution is two steps: work out the vial's concentration, then convert your milligram dose into a volume you can read on the syringe. The units you draw are just that volume expressed on the insulin scale.

Here it is in plain arithmetic:

1. Concentration (mg/mL) = vial mg ÷ bac water mL. A 10 mg vial in 2 mL is 10 ÷ 2 = 5 mg/mL.
2. Volume (mL) = dose mg ÷ concentration. A 2.5 mg dose at 5 mg/mL is 2.5 ÷ 5 = 0.5 mL.
3. Units = volume × 100 on a U-100 syringe (100 units = 1 mL). So 0.5 mL = 50 units.

Collapsed into the single formula the calculator runs:

units = (dose mg ÷ (vial mg ÷ bac water mL)) × 100 = dose mg × bac water mL ÷ vial mg × 100

Sanity-check our example in your head: 2.5 × 2 ÷ 10 × 100 = 50 units. For doses per vial, divide the vial's milligrams by your dose: 10 mg ÷ 2.5 mg = 4 weekly doses.

Our take: The single biggest tirzepatide mistake we see is copying a "units" number from someone else. Units only mean something paired with a concentration. Someone drawing "25 units" of a 10 mg/mL vial is taking the same 2.5 mg as you at "50 units" on a 5 mg/mL vial. Always run your vial and your water through the math — never inherit a unit count.

How much bacteriostatic water should you add to tirzepatide?

There's no single correct volume — pick the amount that lands your dose on an easy-to-read unit mark while keeping the whole titration range on the syringe. Because tirzepatide climbs through a range of doses over weeks, the best water choice reads well not just for your start dose but for where you're heading.

The trade-off is the same as any peptide: less water concentrates the vial (smaller unit draws), more water dilutes it (larger, easier-to-read draws, until they overflow 100 units). The wrinkle with tirzepatide is the climb. On a 10 mg vial in 2 mL (5 mg/mL), your 2.5 mg start is a tidy 50 units, but 5 mg is already a full 100-unit syringe, and 7.5 mg won't fit. That's a sign to use a higher-strength vial or more water as you escalate.

Because ProtocolPlus tracks reconstitutions, we can show the vial-strength × water-volume combinations real tirzepatide users log — the "house ratios" the crowd has settled on.

The pattern: 2 mL is the dominant water choice, and the 20-30 mg vials at 2 mL are the most-logged setups (each about 13% of reconstitutions), making 10-15 mg/mL the everyday concentration band. At 10 mg/mL, a 2.5 mg dose is 25 units and a 5 mg dose is 50 units, comfortably mid-syringe across the early titration steps, which is exactly why the crowd lands there.

How do you read tirzepatide units on an insulin syringe?

On a U-100 insulin syringe, 100 units = 1 mL, so a unit is a hundredth of a millilitre — the calculator converts your milligram dose into that unit mark. The "units" you read are a measure of volume, not of how much tirzepatide you're taking.

This trips people up because "units" sounds like a drug amount. It isn't. Insulin syringes are simply the most precise small-volume syringes widely available, and their numbering describes how full the barrel is. Three calibrations exist and the calculator supports all three:

Always confirm which syringe you're holding before trusting any "units" figure — a number that's right on U-100 is wrong on U-40.

Beyond the calibration, insulin syringes also come in different barrel volumes — commonly 0.3 mL (30 units), 0.5 mL (50 units), and 1.0 mL (100 units) on the U-100 scale. The barrel just sets how much it holds; the unit marks mean the same thing on all of them. The practical guidance: pick the smallest barrel that still fits your draw, because smaller barrels have more widely spaced marks and are easier to read accurately. A 25-unit draw is far more precise on a 0.3 mL (30-unit) barrel than on a 1.0 mL one, while a 75-unit draw needs at least the 1.0 mL barrel. The calculator tells you the unit figure; matching it to a barrel that displays that figure clearly is the last step in getting a repeatable dose.

mg, mcg, units, and mL: keeping the four numbers straight

Milligrams measure the tirzepatide; millilitres and units measure the liquid you draw. Reconstitution is the bridge between them, and confusing the two families is the root of most dosing errors. Tirzepatide lives firmly in the milligram world — doses run 2.5 to 15 mg — so you'll rarely touch micrograms here, but it's worth knowing 1 mg = 1,000 mcg in case you cross-reference a microgram-dosed peptide and mix the scales up.

Here is the same 2.5 mg starting dose expressed four ways on a 5 mg/mL vial, so you can see it's one quantity wearing four labels:

When a calculator, a vendor chart, and a forum post seem to disagree about tirzepatide, this table is almost always the reason: one is quoting a mass and another a volume. Pin down which is which and the contradiction evaporates.

Where does each tirzepatide titration dose land on the syringe?

As tirzepatide titrates from 2.5 mg up to 15 mg, the unit mark you draw climbs with it — and on a single concentration the higher doses quickly fill or overflow the syringe. The table below shows where each studied dose lands at the common concentration bands, so you can see the picture at a glance. These are draw amounts, not a schedule: the FDA-approved titration is a clinical decision (see the linked guide).

For reference, FDA labeling for brand tirzepatide titrates 2.5 mg once weekly to start, increasing by 2.5 mg every 4 weeks as needed, to a maximum of 15 mg (U.S. FDA, 2025, "Mounjaro (tirzepatide) Prescribing Information", retrieved 2026-06-15). Those same dose values are what people enter into a compounded-vial calculator — the difference is that with a vial you must convert each one to units yourself.

Our take: This table is the strongest argument for choosing your water with the whole climb in mind. Reconstitute a 10 mg vial in 2 mL (5 mg/mL) and you're comfortable at 2.5 mg, but you hit the syringe ceiling at 5 mg and can't fit 7.5. A 30 mg vial at 2 mL (15 mg/mL) keeps every dose from 2.5 to 15 mg on a single U-100 syringe. That's the practical reason our usage data clusters at the 10-15 mg/mL band.

Tirzepatide reconstitution chart: units by vial size

If you reconstitute with the most common 2 mL of bacteriostatic water, this chart shows the concentration each vial size makes and the units to draw for every titration dose. It's the quick reference for the standard 2 mL mix; for any other water volume, use the calculator at the top.

A dash means the dose exceeds one 100-unit U-100 syringe at that concentration and would need a second draw or more water. Reading the chart top to bottom shows the trade-off clearly: a 10 mg vial keeps early doses on large, easy marks but runs out of syringe fast, while a 30 mg vial carries the entire 2.5-15 mg range on a single syringe — the reason it's the most-logged size in our data. The 60 mg vial concentrates so much that high doses stay small, but the 2.5 mg start drops to a hard-to-read 8 units.

Common tirzepatide dose conversions

The most-searched single conversions, all at the popular 2 mL mix, so you can sanity-check the tool:

• 2.5 mg tirzepatide in a 10 mg vial + 2 mL (5 mg/mL) = 50 units.
• 5 mg tirzepatide in a 20 mg vial + 2 mL (10 mg/mL) = 50 units.
• 7.5 mg tirzepatide in a 30 mg vial + 2 mL (15 mg/mL) = 50 units.
• 10 mg tirzepatide in a 20 mg vial + 2 mL (10 mg/mL) = 100 units (a full syringe).
• 12.5 mg tirzepatide in a 30 mg vial + 2 mL (15 mg/mL) = 83 units.
• 15 mg tirzepatide in a 30 mg vial + 2 mL (15 mg/mL) = 100 units.

Notice how the same 50-unit draw can mean 2.5, 5, or 7.5 mg depending on the vial — yet more proof that a unit number is meaningless without its concentration.

Where do real tirzepatide doses land?

Across our tracked tirzepatide reconstitutions, the typical draw is about 50 units on a U-100 syringe — right in the comfortable middle of the barrel. Seeing the real distribution is a useful reality check the formula alone can't give you.

The middle of the pack sits near a half-full U-100 syringe (50 units), with the bulk of draws between about 25 and 83 units. That's a comfortable, readable spread, and it reflects the popular 2 mL / mid-strength-vial habit doing its job: keeping the early-to-mid titration on easy marks.

A worked walkthrough: choosing water for the whole climb

Say you have a 30 mg vial and expect to titrate from 2.5 mg up to a 10 mg maintenance dose. Run the candidate water volumes through the formula and look at the whole range, not just the start:

• 2 mL → 15 mg/mL. 2.5 mg = 17 units, 5 mg = 33 units, 10 mg = 67 units. Every dose stays on one U-100 syringe with room to spare. This is the clean choice.
• 3 mL → 10 mg/mL. 2.5 mg = 25 units, 5 mg = 50 units, 10 mg = 100 units. Also works, with slightly easier-to-read early marks, but 10 mg fills the entire syringe (no headroom, and 12.5 mg wouldn't fit).
• 1 mL → 30 mg/mL. 2.5 mg = 8 units, 5 mg = 17 units, 10 mg = 33 units. Compact, but the early doses are small and harder to measure precisely.

The 2 mL option wins because the full 2.5-10 mg range sits comfortably mid-syringe — which is exactly the logic behind the 2 mL clustering in our usage data. Picking the water for your destination dose, not your starting one, is the single most useful habit this calculator encourages.

Switching vials mid-titration: always recalculate

A common moment of confusion is opening a new vial part-way through titration — say moving from a 10 mg vial to a 30 mg vial. Even if you reconstitute both with 2 mL, the concentration changes (5 mg/mL vs 15 mg/mL), so the same dose now draws to a different unit mark. A 5 mg dose was 100 units on the old vial and is 33 units on the new one. Never carry a unit number across vials; re-run the calculator every time the vial strength or water volume changes. This is the most frequent cause of accidental triple-dosing or under-dosing among people who otherwise have the math right.

How many tirzepatide doses are in a vial, and what does each cost?

Doses per vial is just vial milligrams ÷ your weekly dose — and dividing the vial price by that number gives a true cost per dose that the sticker price hides. It's the figure that actually tells you whether a vial is a good deal.

A 10 mg vial dosed at 2.5 mg yields 4 weekly doses (about a month at the start dose); a 30 mg vial at 5 mg gives 6. As you titrate up, doses per vial fall — the same vial that lasted a month at 2.5 mg lasts two weeks at 5 mg. The calculator updates this automatically so you can see how long a given vial really lasts at your current dose.

The number worth comparing across products is cost per dose: a $250 vial yielding 8 doses ($31/dose) beats a $120 vial yielding 3 ($40/dose) despite the lower sticker. Across our tracked tirzepatide vials, the median works out to roughly 4 doses per completed vial at about $56 per dose, but this swings with vial size and how high you've titrated.

For a full week-by-week dose plan rather than a single calculation, see our tirzepatide titration and dose-escalation planner.

Compounded tirzepatide vs Mounjaro and Zepbound: do you even need this calculator?

Only compounded tirzepatide vials need reconstitution and unit math — the FDA-approved brands, Mounjaro and Zepbound, come as fixed-dose pens you dial and inject, no calculator required. Knowing which you have tells you whether this page applies.

Brand tirzepatide is sold by Eli Lilly as Mounjaro (for type 2 diabetes) and Zepbound (for weight management), both single-molecule GIP and GLP-1 receptor agonists first approved in the U.S. in 2022 (U.S. FDA, 2022, "Mounjaro (tirzepatide) approval", retrieved 2026-06-15). These ship as prefilled pens or single-dose vials at set strengths (2.5, 5, 7.5, 10, 12.5, 15 mg), so the dose is fixed at the factory and there's nothing to reconstitute.

Compounded tirzepatide — the lyophilized powder in a vial that this calculator is for — is a different thing entirely. It is not an FDA-approved product, it's mixed by the user from powder and bacteriostatic water, and the exact dose depends on the math above. That flexibility is why a calculator exists, and also why precision matters: there's no pharmacist-set dose backstopping you.

Our take: If you're on a brand pen, you don't need a units calculator at all — dial your prescribed dose and inject. This page matters when you have a compounded vial, where the responsibility for turning milligrams into a syringe mark sits with you. Treat that as a reason to double-check every number, not a shortcut around a prescription.

How to reconstitute tirzepatide, step by step

Add the bacteriostatic water slowly down the vial wall, swirl gently until clear, and never shake. The peptide is delicate, and rough mixing degrades it before your first dose.

1. Calculate first. Use the tool above to set your water volume and target unit mark, so you know "2 mL → draw to 50 units" before you start.
2. Room temperature, then swab. Bring both vials to room temperature and wipe the stoppers with a fresh alcohol swab.
3. Draw your measured water into a reconstitution syringe (easier than the insulin syringe for this step).
4. Add slowly down the wall of the tirzepatide vial, letting the water run onto the glass rather than blasting the powder.
5. Swirl, don't shake. Roll the vial gently until the solution is completely clear.
6. Inspect. A good vial is clear and particle-free; if it stays cloudy or shows floaters, don't use it.
7. Label and refrigerate. Write the reconstitution date on the vial and store it at 2-8 °C, then dose with your insulin syringe at the unit mark the calculator gave you.

Reconstitution troubleshooting

A few situations come up often enough to name:

• The powder won't fully dissolve. Give it time — peptides can take several minutes to go into solution. Keep swirling gently; warmth from your hands helps. If a vial stays cloudy or has visible particles after the powder should have dissolved, don't use it.
• Foam or lots of bubbles. You added the water too fast or shook the vial. Let it settle; the foam will subside. Going forward, run the water down the wall slowly.
• A vacuum pulls water in too fast. Some vials are under vacuum, which can suck the water in hard and foam the solution. Vent by inserting the empty syringe's needle briefly before adding water, or add it more slowly against the vacuum.
• You drew a bubble into the insulin syringe. Tap it to the top and push it out before injecting; an air bubble means you'll under-dose by its volume.

Double-check your dose before you inject

Build one verification habit: after you draw, confirm the unit mark matches what the calculator said for this vial. It takes two seconds and catches the expensive errors. The quickest sanity check is the head-math version of the formula — dose mg × bac mL ÷ vial mg × 100. For a 5 mg dose from a 20 mg vial in 2 mL, that's 5 × 2 ÷ 20 × 100 = 50 units. If the syringe says 50, you're right; if it says 100, you've used the wrong concentration somewhere. Pairing the calculator's number with a quick mental check is how careful users avoid the single most costly mistake — a 2× or 10× dosing error from a concentration or mg/mcg slip.

Common tirzepatide reconstitution mistakes

Most tirzepatide errors come from confusing a weight with a volume, or from picking a water amount that doesn't suit the whole titration. The frequent ones:

• Reading "units" as milligrams. Units are a volume on the syringe; always convert your mg dose through the calculator.
• Copying someone else's unit count. A unit number is only valid for that person's exact concentration. Use your own vial and water.
• Confusing mg with mcg. Tirzepatide is dosed in milligrams (2.5-15 mg), not micrograms — a 1,000× error if mixed up.
• Water volume that can't carry the climb. A vial mixed for a comfortable 2.5 mg can overflow the syringe at 7.5 mg. Plan the concentration for your target dose.
• Wrong syringe scale. A figure correct on U-100 is wrong on U-40. Confirm your barrel.
• Shaking instead of swirling, and not labeling the date.

Tirzepatide vial sizes at a glance

Compounded tirzepatide vials commonly come in 10, 20, 30, 40, and 60 mg, and the bigger the vial, the higher the concentration you can make in the same volume of water. Pick the size that keeps your target dose on a readable, non-overflowing mark.

• 10 mg — fine for the 2.5 mg start, but tight once you pass 5 mg in 2 mL.
• 20-30 mg — the most-logged sizes in our data; at 2 mL they give 10-15 mg/mL, keeping the early-to-mid titration on a single syringe.
• 40-60 mg — higher concentrations for later titration or fewer reconstitutions; watch that small doses don't drop to hard-to-read unit counts.

Whatever the size, let the calculator set your unit mark rather than reusing another vial's number.

Why concentration is the number that actually matters

Concentration (mg/mL) is the hinge of every tirzepatide calculation — it's the single value that connects the milligrams in the vial to the units on the syringe, and it's what you're really choosing when you pick a water volume. Understanding it makes every other figure intuitive.

Think of concentration as an exchange rate between two currencies: milligrams of tirzepatide and millilitres of liquid. A vial at 5 mg/mL "trades" every 1 mL of liquid for 5 mg of drug. Your dose is a fixed amount of tirzepatide, so the concentration tells you how much liquid that dose occupies, and the syringe scale turns that liquid volume into a unit mark. Change the concentration by changing the water and you change the exchange rate — which is why the identical 2.5 mg dose can read as 25 units on one vial and 50 on another.

This is also why you can never compare unit numbers across different reconstitutions. "Draw 50 units" is meaningless without the concentration behind it; 50 units of a 5 mg/mL vial is half the tirzepatide of 50 units of a 10 mg/mL vial. Every "draw X units" instruction you see online is valid only for that person's exact vial strength and water volume. That's the strongest reason to use a calculator tied to your numbers rather than copying a unit figure from a forum, and it's why this tool always shows the concentration next to the unit mark. The same arithmetic powers our general peptide dosage calculator for any other compound.

What you need to reconstitute tirzepatide

A quick supplies checklist for a compounded tirzepatide vial:

• The lyophilized tirzepatide vial (the freeze-dried powder).
• Bacteriostatic water (sterile water with 0.9% benzyl alcohol) as the diluent — not plain or sterile-only water for a multi-dose vial.
• A reconstitution syringe (1-3 mL) to measure and add the water.
• An insulin syringe (U-100, an appropriate barrel size for your draw) to dose.
• Alcohol swabs for both stoppers, and a marker for the reconstitution date.

Everything the calculator outputs maps onto these tools: the reconstitution syringe sets the water, and the insulin syringe reads the unit mark.

Bacteriostatic vs sterile water for tirzepatide

Use bacteriostatic water for a tirzepatide vial you'll draw from over several weeks — the preservative is what makes repeated punctures reasonable. Bacteriostatic water is sterile water with 0.9% benzyl alcohol added, and that alcohol inhibits bacterial growth, so a multi-dose vial stays safer between weekly draws. Sterile Water for Injection has no preservative and is really a single-use diluent, so it's a poor match for a vial that has to last a month of weekly doses. Plain or distilled water is not injectable and should never be used. Since tirzepatide is dosed once weekly and a vial typically spans several doses, bacteriostatic water is the standard choice, and it's what the worked examples here assume.

How long does reconstituted tirzepatide last?

Once mixed, tirzepatide is far less stable than the dry powder, and while there's no validated shelf life for compounded vials, the community convention is to use a refrigerated, still-clear vial within about a month. Treat that as a usage habit, not a measured number.

Peptides in solution degrade through hydrolysis, deamidation, oxidation, and aggregation, accelerated by heat, light, and agitation — which is why a mixed vial belongs in the refrigerator at 2-8 °C, kept dark, and should never be frozen. Discard any vial that turns cloudy, changes color, or shows particles, regardless of the calendar. For the deeper science of temperature, freezing, and degradation signs, see our peptide storage and stability guide.

How precise does your tirzepatide draw need to be?

The draw should be close enough that rounding to the nearest readable unit mark doesn't meaningfully change your dose — which is exactly why concentration choice matters. A unit or two of error is usually trivial at a 50-unit draw, but the same error is large at a 5-unit draw.

Insulin syringes are marked in whole units (some 1 mL barrels in 2-unit steps), so every real draw involves a little rounding. The question is what that rounding costs in milligrams, and that depends on your concentration. On a 15 mg/mL vial, one unit equals 0.15 mg of tirzepatide, so rounding a 17-unit draw to 15 or 20 shifts the dose by a few tenths of a milligram — modest against a 2.5 mg dose. But on a very concentrated 30 mg/mL vial, one unit is 0.3 mg, and small draws get jumpy: an 8-unit start dose is hard to hit within 10%. This is the precision argument for not over-concentrating a vial whose early doses are small — the same point our usage data makes by clustering at the 10-15 mg/mL band, where the common doses land on comfortably large, forgiving unit marks.

The takeaway isn't to chase decimal-perfect draws; it's to reconstitute so your usual doses sit on large enough unit numbers that ordinary rounding is harmless. The calculator's suggested-volume helper aims for that readable zone automatically.

Tirzepatide microdosing and split doses

Some users split a weekly tirzepatide dose into smaller, more frequent injections, or microdose below the standard 2.5 mg start — both are dosing strategies that change the numbers you enter, not the reconstitution math. The calculator handles whatever dose you type; the strategy itself is a separate decision.

If you split a 2.5 mg weekly dose into two 1.25 mg injections, you simply run 1.25 mg through the calculator for each draw — on a 5 mg/mL vial that's 25 units twice instead of 50 units once. Microdosing works the same way: enter the smaller milligram figure and read the (smaller) unit mark, keeping in mind the precision point above — very small draws need a less concentrated vial to stay measurable. Whether splitting or microdosing is appropriate is outside what a calculator can tell you; for the rationale and trade-offs, see our tirzepatide microdosing and split-dose guide. This page's job is only to convert whatever dose you choose into an accurate syringe mark.

Frequently asked questions

Sources

Factual claims (approved strengths, titration, mechanism) are sourced below. Reconstitution arithmetic is universal; dose values in examples follow FDA labeling and are not recommendations. ProtocolPlus usage figures are first-party app data.

1. U.S. FDA (2025) — Mounjaro (tirzepatide) Prescribing Information (strengths 2.5-15 mg per 0.5 mL; start 2.5 mg weekly, +2.5 mg every ≥4 weeks, max 15 mg). https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215866s039lbl.pdf — retrieved 2026-06-15.
2. U.S. FDA (2022) — Mounjaro (tirzepatide) original approval (GIP + GLP-1 receptor agonist; first U.S. approval). https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf — retrieved 2026-06-15.
3. The New England Journal of Medicine (2022) — Jastreboff AM et al., Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). https://www.nejm.org/doi/pdf/10.1056/nejmoa2206038 — retrieved 2026-06-15.
4. ClinicalTrials.gov — NCT04184622 (SURMOUNT obesity program). https://clinicaltrials.gov/study/NCT04184622 — retrieved 2026-06-15.

About this guide. Written by Jordan Vance, peptide and biohacking researcher (placeholder, replace before publish), and medically reviewed by Dr. Maya Ellison, MD, biochemistry (placeholder, replace before publish), for the ProtocolPlus Research Team. This calculator and article are educational and not medical advice.